Rosenblatt raised the firm’s price target on Imax (IMAX) to $42 from $37 and keeps a Buy rating on the shares. The firm says Imax remains its favorite name in the group, driven by continued box office strength in Q3. The company is positioned for another quarter of upside and the Q4 file slate is “chock-full of potential hits,” the analyst tells investors in a research note. Rosenblatt adds that Imax is trading well below the mid-teens multiple the stock has seen historically.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX:
- Imax price target raised to $31 from $28 at JPMorgan
- IMAX: Strong Buy Rating Backed by Exceptional Performance and Growth Prospects
- IMAX’s Strong Market Position and Growth Potential Drive Buy Rating
- Taylor Swift plans return to movie theaters, Hollywood Reporter says
- Imax price target raised to $37 from $32 at Barrington